Oxidative stress and cellular immunity in patients with recurrent aphthous ulcers

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 5, 2014, Pages 355-360

  Avci, E ^a   Akarslan, Z Z ^b   Erten, H ^b   Coskun Cevher, S ^b  

^a HITIT UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Cytokines; Oxidative stress; Recurrent aphthous ulcer

Indexed keywords

GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; FREE RADICAL; PEROXIDASE;

ADULT; ANTIOXIDANT ASSAY; APHTHOUS ULCER; ARTICLE; CELLULAR IMMUNITY; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; MALE; OXIDATIVE STRESS; PARAMETERS; PATHOGENESIS; RECURRENT APHTHOUS ULCER; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS; YOUNG ADULT; APHTHOUS STOMATITIS; BLOOD; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADULT; ANTIOXIDANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FREE RADICALS; GLUTATHIONE; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; MALE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; PEROXIDASE; STOMATITIS, APHTHOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84900034915     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20143714     Document Type: Article

References (40)

1. Caglayan F, Miloglu O, Altun O, Erel O, Yilmaz AB. Oxidative stress and myeloperoxidase levels in saliva of patients with recurrent aphthous stomatitis. Oral Dis 2008; 14: 700-704. doi: 10.1111/j.1601-0825.2008.01466.x.
2. Momen-Beitollahi J, Mansourian A, Momen-Heravi F, Amanlou M, Obradov S, Sahebjamee M. Assessment of salivary and serum antioxidant status in patients with recurrent aphthous stomatitis. Med Oral Patol Oral Cir Bucal 2010; 15: e557-e561. doi: 10.4317/medoral.15.e557.
3. Akoglu G, Metin A, Kilinc F, Pektas SD, Isikoglu S, Akbas A, et al. Total serum oxidant/antioxidant status and arylesterase activity in recurrent aphthous stomatitis. Ann Dermatol 2013; 25: 273-277. doi: 10.5021/ad.2013.25.3.273.
4. Boras VV, Lukac J, Brailo V, Picek P, Kordic D, Zilic IA. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with recurrent aphthous ulceration. J Oral Pathol Med 2006; 35: 241-243. doi: 10.1111/j.1600-0714.2006.00404.x.
5. Eguia-del Valle A, Martinez-Conde-Llamosas R, Lopez- Vicente J, Uribarri-Etxebarria A, Aguirre-Urizar JM. Salivary levels of tumour necrosis factor-alpha in patients with recurrent aphthous stomatitis. Med Oral Patol Oral Cir Bucal 2011; 16: e33-e36.
6. Chapple IL. Role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases. Clin Mol Pathol 1996; 49: M247-M255. doi: 10.1136/mp.49.5.M247.
7. Chapple IL, Brock G, Eftimiadi C, Matthews JB. Glutathione in gingival crevicular fluid and its relation to local antioxidant capacity in periodontal health and disease. Mol Pathol 2002; 55: 367-373. doi: 10.1136/mp.55.6.367.
8. Raborn GW, Grace MG. Recurrent herpes simplex labialis: selected therapeutic options. J Can Dent Assoc 2003; 69: 498-503.
9. Saral Y, Coskun BK, Ozturk P, Karatas F, Ayar A. Assessment of salivary and serum antioxidant vitamins and lipid peroxidation in patients with recurrent aphthous ulceration. Tohoku J Exp Med 2005; 206: 305-312. doi: 10.1620/tjem.206.305.
10. Bosca L, Zeini M, Traves PG, Hortelano S. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Toxicology 2005; 208: 249-258. doi: 10.1016/j.tox.2004.11.035.
11. Kaner D, Bernimoulin JP, Kleber BM, Heizmann WR, Friedmann A. Gingival crevicular fluid levels of calprotectin and myeloperoxidase during therapy for generalized aggressive periodontitis. J Periodontal Res 2006; 41: 132-139. doi: 10.1111/j.1600-0765.2005.00849.x.
12. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994; 94: 437-444. doi: 10.1172/JCI117342.
13. Zouaoui BK, Moguilevsky N, Legssyer I, Babar S, Guillaume M, Delree P, et al. Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation. Biochem Biophys Res Commun 2004; 325: 434-438. doi: 10.1016/j.bbrc.2004.10.049.
14. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003; 66: 1499-1503. doi: 10.1016/S0006-2952(03)00504-5.
15. Pastore A, Piemonte F, Locatelli M, Lo Russo A, Gaeta LM, Tozzi G, et al. Determination of blood total, reduced, and oxidized glutathione in pediatric subjects. Clin Chem 2001; 47: 1467-1469.
16. Scully C, Hodgson T. Recurrent oral ulceration: aphthouslike ulcers in periodic syndromes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106: 845-852. doi: 10.1016/j.tripleo.2008.07.014.
17. Guentsch A, Preshaw PM, Bremer-Streck S, Klinger G, Glockmann E, Sigusch BW. Lipid peroxidation and antioxidant activity in saliva of periodontitis patients: effect of smoking and periodontal treatment. Clin Oral Investig 2008; 12: 345-352. doi: 10.1007/s00784-008-0202-z.
18. Buduneli N, Kardesler L, Isik H, Willis CS III, Hawkins SI, Kinane DF, et al. Effects of smoking and gingival inflammation on salivary antioxidant capacity. J Clin Periodontol 2006; 33: 159-164. doi: 10.1111/j.1600-051X.2006.00892.x.
19. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analyses of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
20. Colowick SP, Kaplan SD (Editors). Myeloperoxidase activity. In: Methods in enzymology. Vol II. New York: Academic Press; 1955. p 769-770.
21. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119. doi: 10.1016/j.clinbiochem.2003.10.014.
22. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-1111. doi: 10.1016/j.clinbiochem.2005.08.008.
23. Niki E. Antioxidant capacity: Which capacity and how to assess it? J Berry Res 2012; 1: 169-176.
24. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996; 41: 2078-2086. doi: 10.1007/BF02093613.
25. Kokcam I, Naziroglu M. Antioxidants and lipid peroxidation status in the blood of patients with psoriasis. Clin Chim Acta 1999; 289: 23-31. doi: 10.1016/S0009-8981(99)00150-3.
26. Cimen MY, Kaya TI, Eskandari G, Tursen U, Ikizoglu G, Atik U. Oxidant/antioxidant status in patients with recurrent aphthous stomatitis. Clin Exp Dermatol 2003; 28: 647-650. doi: 10.1046/j.1365-2230.2003.01415.x.
27. Ozturk P, Belge KE, Ataseven A. Copper/zinc and copper/ selenium ratios, and oxidative stress as biochemical markers in recurrent aphthous stomatitis. J Trace Elem Med Biol 2013; 27: 312-316. doi: 10.1016/j.jtemb.2013.04.002.
28. Karincaoglu Y, Batcioglu K, Erdem T, Esrefoglu M, Genc M. The levels of plasma and salivary antioxidants in the patient with recurrent aphthous stomatitis. J Oral Pathol Med 2005; 34: 7-12. doi: 10.1111/j.1600-0714.2004.00253.x.
29. Gunduz K, Ozturk G, Sozmen EY. Erythrocyte superoxide dismutase, catalase activities and plasma nitrite and nitrate levels in patients with Behcet disease and recurrent aphthous stomatitis. Clin Exp Dermatol 2004; 29: 176-179. doi: 10.1111/j.1365-2230.2004.01488.x.
30. Ozkan Y, Yardim-Akaydin S, Sepici A, Engin B, Sepici V, Simsek B. Assessment of homocysteine, neopterin and nitric oxide levels in Behcet's disease. Clin Chem Lab Med 2007; 45: 73-77. doi: 10.1515/CCLM.2007.018.
31. Stenman G, Heyden G. Premonitory stages of recurrent aphthous stomatitis. I. Histological and enzyme histochemical investigations. J Oral Pathol 1980; 9: 155-162. doi: 10. 1111/j.1600-0714.1980.tb00372.x.
32. Savage NW, Seymour GJ, Kruger BJ. Expression of class I and class II major histocompatibility complex antigens on epithelial cells in recurrent aphthous stomatitis. J Oral Pathol 1986; 15: 191-195. doi: 10.1111/j.1600-0714.1986.tb00605.x.
33. Healy CM, Thornhill MH. Induction of adhesion molecule expression on blood vessels and keratinocytes in recurrent oral ulceration. J Oral Pathol Med 1999; 28: 5-11. doi: 10. 1111/j.1600-0714.1999.tb01986.x.
34. Koybasý S, Parlak AH. Reccurrent aphthous stomatitis. Turkiye Klinkleri J Med Sci 2006; 26: 319-329.
35. Sun A, Chu CT, Liu BY, Wang JT, Leu JS, Chiang CP. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers. Proc Natl Sci Counc Repub China B 2000; 24: 116-122.
36. Buno IJ, Huff JC, Weston WL, Cook DT, Brice SL. Elevated levels of interferon gamma, tumor necrosis factor alpha, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis. Arch Dermatol 1998; 134: 827-831.
37. Cakman I, Rohwer J, Schutz RM, Kirchner H, Rink L. Dysregulation between TH1 and TH2 T cell subpopulations in the elderly. Mech Ageing Dev 1996; 87: 197-209. doi: 10.1016/0047-6374(96)01708-3.
38. Taylor LJ, Bagg J, Walker DM, Peters TJ. Increased production of tumour necrosis factor by peripheral blood leukocytes in patients with recurrent oral aphthous ulceration. J Oral Pathol Med 1992; 21: 21-25. doi: 10.1111/j.1600-0714.1992.tb00963.x.
39. Sepici-Dincel A, Ozkan Y, Yardim-Akaydin S, Kaymak- Karatas G, Onder M, Simsek B. The association between total antioxidant status and oxidative stress in Behcet's disease. Rheumatol Int 2006; 26: 1005-1009. doi: 10.1007/s00296-006-0126-3.
40. Lewkowicz N, Lewkowicz P, Kurnatowska A, Banasik M, Glowacka E, Cedzynski M, et al. Innate immune system is implicated in recurrent aphthous ulcer pathogenesis. J Oral Pathol Med 2003; 32: 475-481. doi: 10.1034/j.1600-0714.2003.00181.x.